DaShenLin Pharmaceutical Group Co., Ltd. (SHA: 603233)

DaShenLin Pharmaceutical Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	15,283	28,359	37,585	33,307	51,603	27,171
Market Cap Growth	-48.95%	-24.55%	12.85%	-35.46%	89.92%	70.41%
Enterprise Value	18,653	31,251	40,044	35,732	49,307	25,680
Last Close Price	13.42	24.41	31.73	27.70	42.44	23.43
PE Ratio	16.77	23.70	34.87	39.57	45.27	36.80
PS Ratio	0.59	1.16	1.77	1.99	3.54	2.44
PB Ratio	2.15	3.57	5.48	5.61	9.26	6.27
P/FCF Ratio	9.35	20.59	13.81	128.08	44.42	22.52
P/OCF Ratio	4.70	8.94	10.01	21.42	26.41	15.91
EV/Sales Ratio	0.72	1.27	1.88	2.13	3.38	2.30
EV/EBITDA Ratio	6.21	15.50	22.15	27.36	32.16	24.25
EV/EBIT Ratio	12.61	17.40	25.18	32.45	36.19	28.03
EV/FCF Ratio	11.41	22.69	14.71	137.41	42.45	21.29
Debt / Equity Ratio	0.86	0.82	0.86	0.89	0.25	0.08
Debt / EBITDA Ratio	2.39	2.02	2.06	2.34	0.91	0.31
Debt / FCF Ratio	4.39	4.73	2.18	20.29	1.20	0.27
Asset Turnover	1.12	1.09	1.11	1.13	1.39	1.47
Inventory Turnover	4.03	3.92	3.53	3.29	3.80	3.43
Quick Ratio	0.55	0.54	0.62	0.55	0.93	0.80
Current Ratio	0.93	0.94	1.10	1.10	1.52	1.37
Return on Equity (ROE)	12.22%	16.63%	16.86%	13.98%	21.87%	18.78%
Return on Assets (ROA)	3.99%	4.99%	5.21%	4.64%	8.11%	7.53%
Return on Capital (ROIC)	6.40%	8.24%	8.28%	7.57%	14.64%	14.14%
Earnings Yield	5.96%	4.11%	2.76%	2.38%	2.06%	2.59%
FCF Yield	10.69%	4.86%	7.24%	0.78%	2.25%	4.44%
Dividend Yield	4.62%	1.27%	1.58%	1.25%	1.09%	1.23%
Payout Ratio	41.19%	51.82%	40.58%	67.53%	31.38%	36.06%
Buyback Yield / Dilution	0.00%	0.50%	-0.69%	0.24%	-2.65%	-2.13%
Total Shareholder Return	4.62%	1.77%	0.88%	1.49%	-1.56%	-0.89%

Source: S&P Capital IQ. Standard template. Financial Sources.